These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 17458251)

  • 1. [Metabolic syndrome and small, dense LDL].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():391-9. PubMed ID: 17458251
    [No Abstract]   [Full Text] [Related]  

  • 2. Small, dense low-density-lipoproteins and the metabolic syndrome.
    Rizzo M; Berneis K
    Diabetes Metab Res Rev; 2007 Jan; 23(1):14-20. PubMed ID: 17080469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome.
    Rizzo M; Pernice V; Frasheri A; Di Lorenzo G; Rini GB; Spinas GA; Berneis K
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):870-5. PubMed ID: 18771560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
    Sjögren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius ML; Fisher RM
    Metabolism; 2008 Mar; 57(3):362-6. PubMed ID: 18249208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria.
    Gazi I; Tsimihodimos V; Filippatos T; Bairaktari E; Tselepis AD; Elisaf M
    Metabolism; 2006 Jul; 55(7):885-91. PubMed ID: 16784959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL heterogeneity revisited: lesson for the metabolic syndrome from a new interpopulation study?
    Chan DC; Watts GF
    Eur J Clin Invest; 2004 Nov; 34(11):719-22. PubMed ID: 15530143
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we measure routinely the LDL peak particle size?
    Rizzo M; Berneis K
    Int J Cardiol; 2006 Feb; 107(2):166-70. PubMed ID: 16412793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein (LDL) particle size in healthy prepubertal children: the STRIP study.
    Kaitosaari T; Rönnemaa T; Viikari J; Leino A; Jokinen E; Simell O
    Acta Paediatr; 2006 Dec; 95(12):1668-73. PubMed ID: 17129981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.
    Kathiresan S; Otvos JD; Sullivan LM; Keyes MJ; Schaefer EJ; Wilson PW; D'Agostino RB; Vasan RS; Robins SJ
    Circulation; 2006 Jan; 113(1):20-9. PubMed ID: 16380547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Small, dense LDL].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():554-62. PubMed ID: 11351649
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic syndrome.
    Erbas T
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S401-4. PubMed ID: 14704875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
    Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
    J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of low-density-lipoproteins size in vascular diseases.
    Rizzo M; Berneis K; Corrado E; Novo S
    Int Angiol; 2006 Mar; 25(1):4-9. PubMed ID: 16520717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia.
    Acibucu F; Kayatas M; Candan F
    Singapore Med J; 2010 Dec; 51(12):931-6. PubMed ID: 21221497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome.
    Park SH; Kim JY; Lee JH; Park HY
    Clin Chim Acta; 2011 Feb; 412(5-6):435-40. PubMed ID: 21093421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome.
    Pettersson C; Karlsson H; Ståhlman M; Larsson T; Fagerberg B; Lindahl M; Wiklund O; Borén J; Fogelstrand L
    J Intern Med; 2011 Mar; 269(3):306-21. PubMed ID: 21205019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small, dense low density lipoprotein (LDL) and the insulin resistance syndrome (IRS).
    Festa A
    Clin Lab; 2001; 47(3-4):111-8. PubMed ID: 11294573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and renal failure: similarities and differences.
    Kaysen GA
    Panminerva Med; 2006 Sep; 48(3):151-64. PubMed ID: 17122751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.